Effects of Exemestane and Tamoxifen treatment on bone texture analysis assessed by TBS in comparison with bone mineral density assessed by DXA in women with breast cancer Aromatase inhibitor, Breast cancer, Cancer, Exemestane, GE-Lunar, Germany, Longitudinal, Secondary osteoporosis, Tamoxifen, Treatment (anti-osteoporotic treatments)